Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '24-HOUR INTRAGASTRIC PH' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 26 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Huang, JQ; Hunt, RH
      Pharmacological and pharmacodynamic essentials of H-2-receptor antagonistsand proton pump inhibitors for the practising physician

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    2. van Leerdam, ME; Rauws, EAJ
      The role of acid suppressants in upper gastrointestinal ulcer bleeding

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    3. Stedman, CAM; Barclay, ML
      Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    4. Katz, PO; Hatlebakk, JG; Castell, DO
      Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    5. Gerson, LB; Hatton, BN; Ryono, R; Jones, W; Pulliam, G; Sampliner, RE; Triadafilopoulos, G; Fass, R
      Clinical and fiscal impact of lansoprazole intolerance in veterans with gastro-oesophageal reflux disease

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    6. Fass, R; Murthy, U; Hayden, CW; Malagon, IB; Pulliam, G; Wendel, C; Kovacs, TOG
      Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy - a prospective, randomized, multi-centre study

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    7. Jungnickel, PW
      Pantoprazole: A new proton pump inhibitor

      CLINICAL THERAPEUTICS
    8. Metz, DC
      Potential uses of intravenous proton pump inhibitors to control gastric acid secretion

      DIGESTION
    9. Katz, PO
      Pharmacologic basis of pantoprazole dosing

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    10. Byrne, MF; Murray, FE
      Formulary management of proton pump inhibitors

      PHARMACOECONOMICS
    11. Dammann, HG; Burkhardt, F
      Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    12. Miwa, H; Nagahara, A; Sato, K; Ohkura, R; Murai, T; Shimizu, H; Watanabe, S; Sato, N
      Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    13. Vallot, T; Carella, G
      Efficacy of proton pump inhibitors in the treatment of gastro-esophageal reflux disease.

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    14. Barkun, AN; Cockeram, AW; Plourde, V; Fedorak, RN
      Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    15. Sheu, BS; Chi, CH; Yang, HB; Jen, CM; Lin, XZ
      A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer

      HEPATO-GASTROENTEROLOGY
    16. Bardhan, KD
      Pantoprazole: A new proton pump inhibitor in the management of upper gastrointestinal disease

      DRUGS OF TODAY
    17. BLUM RA; HUNT RH; KIDD SL; SHI H; JENNINGS DE; GRESKIROSE PA
      DOSE-RESPONSE RELATIONSHIP OF LANSOPRAZOLE TO GASTRIC-ACID ANTISECRETORY EFFECTS

      Alimentary pharmacology & therapeutics
    18. GEUS WP; MULDER PGH; NICOLAI JJ; VANDENBOOMGAARD DM; LAMERS CBHW
      ACID-INHIBITORY EFFECTS OF OMEPRAZOLE AND LANSOPRAZOLE IN HELICOBACTER PYLORI-NEGATIVE HEALTHY-SUBJECTS

      Alimentary pharmacology & therapeutics
    19. PETERSEN KU
      PROTON PUMP INHIBITORS - WHAT IS THE MERI T OF THE LATER ENTRIES

      Leber, Magen, Darm
    20. ZIMMERMANN AE; KATONA BG
      LANSOPRAZOLE - A COMPREHENSIVE REVIEW

      Pharmacotherapy
    21. BRUMMER RJM; GEERLING BJ; STOCKBRUGGER RW
      INITIAL AND CHRONIC GASTRIC-ACID INHIBITION BY LANSOPRAZOLE AND OMEPRAZOLE IN RELATION TO MEAL ADMINISTRATION

      Digestive diseases and sciences
    22. HASSELGREN G; LIND T; LUNDELL L; AADLAND E; EFSKIND P; FALK A; HYLTANDER A; SODERLUND C; ERIKSSON S; FERNSTROM P
      CONTINUOUS INTRAVENOUS-INFUSION OF OMEPRAZOLE IN ELDERLY PATIENTS WITH PEPTIC-ULCER BLEEDING - RESULTS OF A PLACEBO-CONTROLLED MULTICENTER STUDY

      Scandinavian journal of gastroenterology
    23. COLIN R; CHASSANY O; BERNADES P; COFFIN JC; DEKORWIN JD; DUMARCET N; GOLDFAIN D; JACQUES JP; MAIRESSE JP; MOLINARI M; SAUTRON JB; AULANIER S; BERGMANN JF; BIGARD MA; BOMMELAER G; BORDERIE P; BOU G; BOYER J; DARNIS F; DASRIAUX M; EUGENE C; FORTIER B; GALLOIS P; GALMICHE JP; GAY G; GUYOT P; HOUCKE PE; LACAINE F; LAPUELLE J; LOEVE JF; MASBERNAT J; MIGNON M; MIGNOT G; NOTINI JL; POYNARD T; REGENSBERG C; SCHOTT AM; SEBERT JL; VICARI F; ZEITOUN P
      ANTIULCER AGENTS - RECOMMENDATIONS AND ME DICAL REFERENCES

      Gastroenterologie clinique et biologique
    24. WILDERSMITH CH; BETTSCHEN HU; MERKI HS
      INDIVIDUAL AND GROUP DOSE-RESPONSES TO INTRAVENOUS OMEPRAZOLE IN THE FIRST 24-H - PH-FEEDBACK-CONTROLLED AND FIXED-DOSE INFUSIONS

      British journal of clinical pharmacology
    25. SAVARINO V; MELA GS; ZENTILIN P; LARGHERO G; CUTELA P; MELE MR; VASSALLO A; MANSI C; DALLORTO E; CELLE G
      BOLUS INFUSION OF FAMOTIDINE - EFFECTS ON GASTRIC PH BY REPEATED 12-HOUR DOSES OF 20 MG IN POSTOPERATIVE-PATIENTS

      Journal of clinical pharmacology
    26. FRESTON JW
      FUTURE-PROSPECTS FOR PROTON PUMP INHIBITORS

      Alimentary pharmacology & therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 11:55:31